{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T03:13:28Z","timestamp":1779333208960,"version":"3.51.4"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:00:00Z","timestamp":1777075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100018208","name":"Cure JM Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018208","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To evaluate the measurement properties of functional performance measures (FPMs), broad jump (BJ) and 10-m run (10MR) in JDM, and to assess their added value alongside conventional clinical tools.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This longitudinal cohort study included 39 children with JDM. BJ and 10MR were assessed with Physician Global Assessment of Disease Activity (PGA), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Manual Muscle Testing in 8 muscles (MMT8) and the Childhood Myositis Assessment Scale (CMAS) at baseline and follow-up visits (every 3\u20136\u2009months). Construct validity and responsiveness were assessed through cross-sectional and longitudinal analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>FPMs correlated significantly with disease activity and muscle function, with faster 10MR and longer BJ performance associated with lower PGA and higher CMAS\/MMT8. 10MR and BJ demonstrated moderate responsiveness (standardized response mean\u2009=\u2009\u22120.56 and 0.31, respectively), and longitudinal analyses confirmed that FPM changes paralleled improvements in CMAS and MMT8 over time. Within the clinically inactive disease (CID) group, functional heterogeneity was evident. Cluster analysis based on CMAS and MMT8 identified a subgroup with relatively low strength scores and poor FPM performance, while a more comprehensive four-variable clustering using BJ, 10MR, CMAS and MMT8 further stratified CID patients into three distinct phenotypes. Notably, one subgroup exhibited high CMAS\/MMT8 scores but reduced FPMs, indicating residual functional impairment not captured by traditional assessments. Low internal consistency (Cronbach\u2019s \u03b1\u2009=\u20090.44) further suggested that FPMs capture dimensions distinct from CMAS\/MMT8.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>FPMs are quick, feasible tools that may provide complementary information on dynamic muscle performance not fully captured by CMAS or MMT8. Their ability to identify functional variability within CID patients supports their potential utility in monitoring functional recovery in JDM.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keag232","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T11:43:13Z","timestamp":1776944593000},"source":"Crossref","is-referenced-by-count":0,"title":["Beyond muscle strength: functional performance measures enhance assessment of disease activity in juvenile dermatomyositis"],"prefix":"10.1093","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-3995-6697","authenticated-orcid":false,"given":"Jia","family":"Shi","sequence":"first","affiliation":[{"name":"Division of Rheumatology, University of Washington , Seattle, WA,","place":["USA"]},{"name":"Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, State Key Laboratory of Common Mechanism Research for Major Diseases , Beijing,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Carpenter","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Seattle Children\u2019s Hospital and Research Center, University of WA , Seattle, WA,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Wong","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Seattle Children\u2019s Hospital and Research Center, University of WA , Seattle, WA,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4541-9898","authenticated-orcid":false,"given":"Qian","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, State Key Laboratory of Common Mechanism Research for Major Diseases , Beijing,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Lood","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, University of Washington , Seattle, WA,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Shenoi","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Seattle Children\u2019s Hospital and Research Center, University of WA , Seattle, WA,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,4,25]]},"reference":[{"key":"2026052022265094600_keag232-B1","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/nrrheum.2018.33","article-title":"Update on outcome assessment in myositis","volume":"14","author":"Rider","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"2026052022265094600_keag232-B2","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1080\/08916930600622553","article-title":"Clinical assessment in juvenile dermatomyositis","volume":"39","author":"Ravelli","year":"2006","journal-title":"Autoimmunity"},{"key":"2026052022265094600_keag232-B3","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/acr.20035","article-title":"Validation of manual muscle testing and a subset of eight muscles for adult and juvenile idiopathic inflammatory myopathies","volume":"62","author":"Rider","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2026052022265094600_keag232-B4","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1002\/art.20179","article-title":"Validation and clinical significance of the Childhood Myositis Assessment Scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies","volume":"50","author":"Huber","year":"2004","journal-title":"Arthritis Rheum"},{"key":"2026052022265094600_keag232-B5","doi-asserted-by":"publisher","first-page":"S118","DOI":"10.1002\/acr.20532","article-title":"Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient\/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)\/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), physician global damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI)","volume":"63","author":"Rider","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2026052022265094600_keag232-B6","volume-title":"Eurofit for adults: assessment of health-related fitness","author":"Oja","year":"1995"},{"key":"2026052022265094600_keag232-B7","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.nmd.2021.08.010","article-title":"Natural history of 10-meter walk\/run test performance in spinal muscular atrophy: a longitudinal analysis","volume":"32","author":"Krosschell","year":"2022","journal-title":"Neuromuscul Disord"},{"key":"2026052022265094600_keag232-B8","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1002\/mus.27147","article-title":"12-Month progression of motor and functional outcomes in congenital myotonic dystrophy","volume":"63","author":"Quigg","year":"2021","journal-title":"Muscle Nerve"},{"key":"2026052022265094600_keag232-B9","doi-asserted-by":"publisher","first-page":"e461","DOI":"10.1212\/wnl.0000000000006858","article-title":"Assessment of disease progression in dysferlinopathy: a 1-year cohort study","volume":"92","author":"Moore","year":"2019","journal-title":"Neurology"},{"key":"2026052022265094600_keag232-B10","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1002\/mus.27119","article-title":"Walking activity in a large cohort of boys with Duchenne muscular dystrophy","volume":"63","author":"Lott","year":"2021","journal-title":"Muscle Nerve"},{"key":"2026052022265094600_keag232-B11","doi-asserted-by":"publisher","first-page":"939","DOI":"10.3233\/jnd-210646","article-title":"The Minimal Clinical Important Difference (MCID) in annual rate of change of timed function tests in boys with DMD","volume":"8","author":"Duong","year":"2021","journal-title":"J Neuromuscul Dis"},{"key":"2026052022265094600_keag232-B12","doi-asserted-by":"publisher","first-page":"S70","DOI":"10.1097\/00002060-199509001-00003","article-title":"Profiles of neuromuscular diseases. Duchenne muscular dystrophy","volume":"74","author":"McDonald","year":"1995","journal-title":"Am J Phys Med Rehabil"},{"key":"2026052022265094600_keag232-B13","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s00431-022-04741-z","article-title":"Physical fitness throughout chemotherapy in children with acute lymphoblastic leukaemia and lymphoma","volume":"182","author":"Vriens","year":"2023","journal-title":"Eur J Pediatr"},{"key":"2026052022265094600_keag232-B14","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1519\/jsc.0000000000000864","article-title":"Reliability and validity of tests to assess lower-body muscular power in children","volume":"29","author":"Fernandez-Santos","year":"2015","journal-title":"J Strength Cond Res"},{"key":"2026052022265094600_keag232-B15","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1136\/archdischild-2014-307396","article-title":"Timed motor function tests capacity in healthy children","volume":"101","author":"Pereira","year":"2016","journal-title":"Arch Dis Child"},{"key":"2026052022265094600_keag232-B16","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1093\/rheumatology\/kes232","article-title":"Aerobic fitness after JDM\u2014a long-term follow-up study","volume":"52","author":"Mathiesen","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"2026052022265094600_keag232-B17","doi-asserted-by":"publisher","first-page":"827","DOI":"10.3899\/jrheum.160997","article-title":"Submaximal exercise capacity in juvenile dermatomyositis after longterm disease: the contribution of muscle, lung, and heart involvement","volume":"44","author":"Berntsen","year":"2017","journal-title":"J Rheumatol"},{"key":"2026052022265094600_keag232-B18","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1056\/nejm197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"2026052022265094600_keag232-B19","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1002\/art.40320","article-title":"2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups","volume":"69","author":"Lundberg","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2026052022265094600_keag232-B20","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1123\/pes.2016-0076","article-title":"Reference values of standing long jump in preschool children: a population-based study","volume":"29","author":"Latorre-Roman","year":"2017","journal-title":"Pediatr Exerc Sci"},{"key":"2026052022265094600_keag232-B21","doi-asserted-by":"publisher","first-page":"99","DOI":"10.4236\/health.2014.61016","article-title":"First normative reference of standing long jump indicates gender difference in lower muscular strength of Macedonian school children","volume":"06","author":"Gontarev","year":"2014","journal-title":"Health"},{"key":"2026052022265094600_keag232-B22","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1136\/annrheumdis-2012-201483","article-title":"The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis","volume":"72","author":"Lazarevic","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"2026052022265094600_keag232-B23","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1002\/art.39200","article-title":"Analysis of published criteria for clinically inactive disease in a large juvenile dermatomyositis cohort shows that skin disease is underestimated","volume":"67","author":"Almeida","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"2026052022265094600_keag232-B24","doi-asserted-by":"publisher","first-page":"9050","DOI":"10.4081\/ejtm.2019.9050","article-title":"Percentile values of the standing broad jump in children and adolescents aged 6-18 years old","volume":"30","author":"Thomas","year":"2020","journal-title":"Eur J Transl Myol"},{"key":"2026052022265094600_keag232-B25","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s11136-010-9606-8","article-title":"The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study","volume":"19","author":"Mokkink","year":"2010","journal-title":"Qual Life Res"},{"key":"2026052022265094600_keag232-B26","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.csbj.2019.04.009","article-title":"Accounting for biological variation with linear mixed-effects modelling improves the quality of clinical metabolomics data","volume":"17","author":"Wanichthanarak","year":"2019","journal-title":"Comput Struct Biotechnol J"},{"key":"2026052022265094600_keag232-B27","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1213\/ane.0000000000002864","article-title":"Correlation coefficients: appropriate use and interpretation","volume":"126","author":"Schober","year":"2018","journal-title":"Anesth Analg"},{"key":"2026052022265094600_keag232-B28","doi-asserted-by":"publisher","first-page":"266","DOI":"10.36185\/2532-1900-029","article-title":"Core myopathies - a short review","volume":"39","author":"Topaloglu","year":"2020","journal-title":"Acta Myol"},{"key":"2026052022265094600_keag232-B29","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s13023-021-01771-y","article-title":"Observation of the natural course of type 3 spinal muscular atrophy: data from the polish registry of spinal muscular atrophy","volume":"16","author":"Lusakowska","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"2026052022265094600_keag232-B30","doi-asserted-by":"publisher","first-page":"2824","DOI":"10.1093\/brain\/awn189","article-title":"Endurance training improves fitness and strength in patients with Becker muscular dystrophy","volume":"131","author":"Sveen","year":"2008","journal-title":"Brain"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keag232\/68160014\/keag232.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/65\/5\/keag232\/68160014\/keag232.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/65\/5\/keag232\/68160014\/keag232.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T02:26:58Z","timestamp":1779330418000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/doi\/10.1093\/rheumatology\/keag232\/8662569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,25]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5,5]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keag232","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5]]},"published":{"date-parts":[[2026,4,25]]},"article-number":"keag232"}}